Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus

Introduction. The aim of the present study was to examine placental levels of DUSP9 mRNA and protein and to investigate the potential role of DUSP9 in the development of gestational diabetes mellitus (GDM). Methods. Placental tissues from pregnant women with GDM (n=17) and normal healthy pregnant wo...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiang Wei, Xiaomin Pu, Li Zhang, Yi Xu, Meifan Duan, Yuemei Wang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2019/1963178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558060562808832
author Qiang Wei
Xiaomin Pu
Li Zhang
Yi Xu
Meifan Duan
Yuemei Wang
author_facet Qiang Wei
Xiaomin Pu
Li Zhang
Yi Xu
Meifan Duan
Yuemei Wang
author_sort Qiang Wei
collection DOAJ
description Introduction. The aim of the present study was to examine placental levels of DUSP9 mRNA and protein and to investigate the potential role of DUSP9 in the development of gestational diabetes mellitus (GDM). Methods. Placental tissues from pregnant women with GDM (n=17) and normal healthy pregnant women (n=16) were collected at delivery. The expression of DUSP9 mRNA in placental tissue was analyzed by real-time PCR, while the expression of DUPS9 protein was evaluated by immunohistochemistry and western blot. Differences in the expression levels of DUSP9 mRNA and protein between the two groups were assessed, as well as potential correlations between DUSP9 mRNA expression levels and relevant clinical indicators. Results. Blood glucose levels were significantly higher in the GDM group than in the control group, based on an oral glucose tolerance test. DUSP9 protein was expressed in the placental cytotrophoblasts in both groups, and placental levels of DUSP9 protein and mRNA were significantly higher in women with GDM. Placental DUSP9 mRNA levels in all 33 women correlated moderately with delivery gestational week (R=0.465, P=0.006), fasting plasma glucose (R=0.350, P=0.046), 1-hour postload plasma glucose (R=0.363, P = 0.038), and 2-hour postload plasma glucose (R=0.366, P=0.036), but not with maternal age, preconception body mass index, prenatal body mass index, or neonatal birth weight. Multiple linear regression analysis indicated that delivery gestational week was an influence factor of DUSP9 mRNA levels (β1=0.026, P<0.05). Conclusions. DUSP9 upregulation in the placenta of GDM pregnant women may promote insulin resistance, which may correlate with the occurrence of GDM. But there is still possibility that DUSP9 upregulation was the results of insulin resistance and/or hyperglycemia. Further research is needed to explore the role of DUSP9 in GDM.
format Article
id doaj-art-b6ae5423f66d4ff2b99ddd61ab76afaa
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-b6ae5423f66d4ff2b99ddd61ab76afaa2025-02-03T01:33:28ZengWileyJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/19631781963178Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes MellitusQiang Wei0Xiaomin Pu1Li Zhang2Yi Xu3Meifan Duan4Yuemei Wang5Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, ChinaIntroduction. The aim of the present study was to examine placental levels of DUSP9 mRNA and protein and to investigate the potential role of DUSP9 in the development of gestational diabetes mellitus (GDM). Methods. Placental tissues from pregnant women with GDM (n=17) and normal healthy pregnant women (n=16) were collected at delivery. The expression of DUSP9 mRNA in placental tissue was analyzed by real-time PCR, while the expression of DUPS9 protein was evaluated by immunohistochemistry and western blot. Differences in the expression levels of DUSP9 mRNA and protein between the two groups were assessed, as well as potential correlations between DUSP9 mRNA expression levels and relevant clinical indicators. Results. Blood glucose levels were significantly higher in the GDM group than in the control group, based on an oral glucose tolerance test. DUSP9 protein was expressed in the placental cytotrophoblasts in both groups, and placental levels of DUSP9 protein and mRNA were significantly higher in women with GDM. Placental DUSP9 mRNA levels in all 33 women correlated moderately with delivery gestational week (R=0.465, P=0.006), fasting plasma glucose (R=0.350, P=0.046), 1-hour postload plasma glucose (R=0.363, P = 0.038), and 2-hour postload plasma glucose (R=0.366, P=0.036), but not with maternal age, preconception body mass index, prenatal body mass index, or neonatal birth weight. Multiple linear regression analysis indicated that delivery gestational week was an influence factor of DUSP9 mRNA levels (β1=0.026, P<0.05). Conclusions. DUSP9 upregulation in the placenta of GDM pregnant women may promote insulin resistance, which may correlate with the occurrence of GDM. But there is still possibility that DUSP9 upregulation was the results of insulin resistance and/or hyperglycemia. Further research is needed to explore the role of DUSP9 in GDM.http://dx.doi.org/10.1155/2019/1963178
spellingShingle Qiang Wei
Xiaomin Pu
Li Zhang
Yi Xu
Meifan Duan
Yuemei Wang
Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
Journal of Diabetes Research
title Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
title_full Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
title_fullStr Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
title_full_unstemmed Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
title_short Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
title_sort expression of dual specificity phosphatase 9 in placenta and its relationship with gestational diabetes mellitus
url http://dx.doi.org/10.1155/2019/1963178
work_keys_str_mv AT qiangwei expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus
AT xiaominpu expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus
AT lizhang expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus
AT yixu expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus
AT meifanduan expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus
AT yuemeiwang expressionofdualspecificityphosphatase9inplacentaanditsrelationshipwithgestationaldiabetesmellitus